We thus conclude that XRCC1 mRNA levels along with ALDH2 mRNA levels may be used for stratification in order to predict the 5-year overall survival rate in liver and lung cancer patients and to refine their treatment strategy. This evidence concerns the gene XRCC1 and lung cancer.